Inhaled Growth Hormone (GH) Compared with Subcutaneous GH in Children with GH Deficiency: Pharmacokinetics, Pharmacodynamics, and Safety | Zendy

Emily C. Walvoord | Zendy; Amparo de la Peña | Zendy; Soomin Park | Zendy; Bernard L. Silverman | Zendy; Leona Cuttler | Zendy; Susan R. Rose | Zendy; Gordon B. Cutler | Zendy; Stenvert L. S. Drop | Zendy; John J. Chipman | Zendy

Open Access

Inhaled Growth Hormone (GH) Compared with Subcutaneous GH in Children with GH Deficiency: Pharmacokinetics, Pharmacodynamics, and Safety

Author(s) -

Emily C. Walvoord,

Amparo de la Peña,

Soomin Park,

Bernard L. Silverman,

Leona Cuttler,

Susan R. Rose,

Gordon B. Cutler,

Stenvert L. S. Drop,

John J. Chipman

Publication year - 2009

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2008-1897

Subject(s) - tolerability , inhalation , medicine , pharmacokinetics , crossover study , placebo , pharmacodynamics , bioavailability , confidence interval , somatropin , endocrinology , growth hormone , area under the curve , adverse effect , pharmacology , anesthesia , hormone , alternative medicine , pathology

Delivery of GH via inhalation is a potential alternative to injection. Previous studies of inhaled GH in adults have demonstrated safety and tolerability.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research